We are live on ! Find out more
WVE icon

Wave Life Sciences

90 hedge funds and large institutions have $306M invested in Wave Life Sciences in 2020 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 28 increasing their positions, 24 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 9

42% more call options, than puts

Call options by funds: $1.71M | Put options by funds: $1.21M

17% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 24

15% more funds holding

Funds holding: 78 → 90 (+12)

4.8% less ownership

Funds ownership: 87.15% → 82.35% (-4.8%)

11% less capital inflows, than outflows

Capital inflows: $50.1M | Capital outflows: $56.5M

Holders
90
Holders Change
+12
Holders Change %
+15.38%
% of All Funds
1.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
28
Reduced
24
Closed
9
Calls
$1.71​M
Puts
$1.21​M
Net Calls
+$504​K
Net Calls Change
-⁠$1.42​M

WVE Hedge Fund Activity: Q2 2020 in Review

90 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q2 2020, worth a combined $306M — up 8.6% from $282M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new WVE positions and 9 closed out — a net gain of 13 holders — while 28 added to existing stakes and 24 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $7.28M. The largest seller was Redmile Group, cutting an estimated $23.6M.

  • 90 institutional investors held Wave Life Sciences (WVE) as of Q2 2020, up from 78 in Q1 2020.
  • Funds reported $306M of Wave Life Sciences stock for Q2 2020, up 8.6% quarter-over-quarter.
  • 22 funds opened new Wave Life Sciences positions in Q2 2020 and 9 closed out, a net change of +13 holders.
  • The largest Wave Life Sciences buyer in Q2 2020 was Nantahala Capital Management, an estimated $7.28M added.
  • The largest Wave Life Sciences seller in Q2 2020 was Redmile Group, an estimated $23.6M sold.

Based on aggregated 13F filings for Q2 2020.